Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.9 USD | -2.11% |
|
+4.59% | -16.41% |
07-11 | Piper Sandler Trims Price Target on Perrigo to $35 From $36, Maintains Overweight Rating | MT |
07-10 | Perrigo Divests HRA Pharma Rare Diseases Business to Esteve Healthcare | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.41% | 3.67B | |
+63.05% | 856B | |
+39.01% | 631B | |
-4.78% | 359B | |
+17.52% | 325B | |
+8.43% | 297B | |
+13.72% | 244B | |
+5.19% | 234B | |
+16.54% | 226B | |
+14.63% | 177B |
- Stock Market
- Equities
- PRGO Stock
- News Perrigo Company plc
- Perrigo Divests HRA Pharma Rare Diseases Business to Esteve Healthcare